Research Article
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy
Figure 2
Overall Survival (a) and Progression-Disease Free Survival (b) (Kaplan-Meier method) according to standard (SDRT-TMZ) versus escalated (HDRT-TMZ) RT dose (log-rank test value < 0,05) in unmethylated patients.
(a) |
(b) |